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Abstract Evolution of CO2 from labelled glucose microinjected
into frog oocytes in vivo may be ascribed to the pentose-P
pathway, as measured by radioactive CO2 production from
[1-14C] and [6-14C]glucose. Coinjection of NADP+ and
[14C]glucose significantly stimulated 14CO2 production. The
effect depends on the amount of NADP+ injected, half maximal
stimulation being obtained at 0.13 mM. The increase in CO2
production was also observed with microinjected glucose-1-P,
glucose-6-P or fructose-6-P used as substrates. Phenazine
methosulfate, mimicked the effects of NADP+. A high
NADPH/NADP+ ratio of 4.3 was found in the cells, the
intracellular concentration of NADP+ being 19 WM.
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1. Introduction
Frog oocytes can be used as in vivo test tubes for the study
of the operation and regulation of glucose metabolism, among
other reasons because the controlled variation of intracellular
levels of intermediates and cofactors, which cannot otherwise
enter the cell, is easily achieved through microinjection.
Glycolysis is operative in grown amphibian oocytes [1],
although glucose injected into the cells is mostly utilized for
glycogen synthesis [2,3]. Glucose incorporation into the poly-
saccharide occurs preferentially by the so called indirect path-
way, which involves prior degradation of glucose into three
carbon compounds which then by gluconeogenesis, regenerate
hexoses-P and UDP-glucose, the proximate glycogen precur-
sor [4]. The key gluconeogenic enzymes phosphoenolpyruvate
carboxykinase and fructose bisphosphatase are present in oo-
cytes [4,5]. Recently, we have reported an important role of
fructose 2,6-bisphosphate in the regulation of glucose metab-
olism in these cells [6].
A minor portion of the glucose microinjected into frog oo-
cytes (around 5%) is released by the cells as CO2 mainly
through the pentose phosphate pathway [2,7]. This route,
which has been considered as an alternative pathway for glu-
cose degradation, diverts some glucose-6-P from glycolysis.
We have taken advantage of the properties of the frog grown
oocyte [8], which has allowed us to follow the in vivo oper-
ation of the pentose phosphate cycle, and to examine under in
vivo conditions, the proposition that the level of the oxidized
form of NADP controls the £ux of carbon through the path-
way [9^11]. Since in our experimental system the direct micro-
injection of cofactors and substrates is easily achieved, we
have been able to unambiguously demonstrate that in vivo
CO2 production by frog oocytes is accomplished by the pen-
tose phosphate pathway, and that increased levels of NADP
indeed stimulate the £ux of glucose through the oxidative arm
of the pentose-P cycle.
2. Materials and methods
2.1. Materials
Glucose, glucose-6-P, glucose-1-P, fructose-6-P, UDP-glucose,
phenazine methosulfate, nicotinamide and nicotinamide adenine nu-
cleotides were from Sigma. All labelled compounds were from Amer-
sham. Before the experiment aliquots of radioactive compounds were
dried under N2 to remove ethanol, carrier solutions were added and
resuspended in saline to achieve the desired concentration. High per-
formance liquid chromatography using a Dionex CarboPac PA1 col-
umn was used to check for partial hydrolysis of metabolite commer-
cial preparations.
2.2. Cells
Stage VI oocytes from freshly killed chilean leptodactylid frogs
(Caudiverbera caudiverbera) were used. This frog was preferred be-
cause of its local availability but mainly because of the large size of
its oocytes (2.2 mm diameter). A few experiments with cells from
Xenopus laevis or Rana pipiens showed the same results (data not
shown).
2.3. Metabolic labelling
Microinjection procedures, handling of compounds to be injected,
and measurement of radioactivity in CO2 were exactly as described
[2]. In short, approximately 50 nl of modi¢ed Barth saline [12] con-
taining labelled glucose (or other radioactive precursors), alone or in a
mixture with NADP or related compounds were injected into oo-
cytes. The incubation of six to eight oocytes was at 22‡C under a
stream of 100% O2. Continuous monitoring of CO2 evolution was
performed as described [13]. The nature and speci¢c radioactivity of
the labelled compounds are described in the legends to Tables and
Figures. For every condition tested, three to ¢ve oocytes, microin-
jected and incubated as zero time controls, were processed through
the fractionation protocol. Radioactivity found in these blanks was
averaged and subtracted from each experimental value. Results are
expressed as carbon radioactivity recovered in CO2 or as a percentage
of control values. We assume that metabolic reactions are initiated by
the injection of substrates, i.e. pre-experimental rates and metabolite
concentrations are very low in oocytes.
2.4. Determination of reduced and oxidized forms of pyridine nucleotide
levels
Pyridine nucleotide levels were measured in non-perturbed oocytes
by means of the £uorometric assay described [14]. The excitation
wavelength was set at 340 nm and emission at 460 nm was recorded.
For the determination of the oxidized forms of nucleotides, groups of
10 oocytes were homogenized in 0.02 N H2SO4-0.1 M Na2SO4 solu-
tion and heated for 30 min at 60‡C in order to destroy the reduced
nucleotide forms. The homogenate was then neutralized with 1 M
Tris-2.5 M NaOH 5:1 and centrifuged at 10 000 rpm for 15 min.
An aliquot of the supernatant solution was used to measure NAD
plus NADP by converting them to their highly £uorescent products
(treatment with 6 N NaOH and heating for 20 min at 60‡C). Another
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aliquot of the supernatant liquid was incubated with 2.5 mM glucose-
6-P and 0.25 units of yeast glucose-6-P dehydrogenase for 30 min at
room temperature, in order to convert NADP into NADPH. The
NAD present was measured in an aliquot of this fraction prior
treatment of the sample with 0.2 N HCl followed by heating 15 min
at 60‡C to destroy NADPH, and subsequent conversion of NAD to
the respective high £uorescent product (treatment with 6 N NaOH
and heating). Another aliquot of the enzymatic treated sample was
used to estimate the NADPH concentration by incubation in 0.05 N
NaOH for 15 min at 60‡C (which destroys NAD) ; then the remain-
ing NADPH was oxidized and converted to the highly £uorescent
product by treatment with 0.03% H2O2-6 N NaOH and heating for
20 min at 60‡C.
The reduced forms of pyridine nucleotides (NADH and NADPH)
were extracted by homogenizing 10 oocytes in 1 ml of 0.045 N NaOH,
followed by heating at 60‡C for 20 min, neutralization with 1 M Tris-
0.1 M HCl 1:1 and centrifugation at 10 000 rpm for 15 min. An
aliquot of the supernatant solution was treated with 0.03% H2O2-6
N NaOH and heated for 20 min at 60‡C for measurement of NADH
plus NADPH levels. A second aliquot was incubated with 0.4 units of
alcohol-dehydrogenase and 20 mM acetaldehyde for 30 min at room
temperature in order to oxidize NADH. NAD present in this frac-
tion was determined by conversion to the respective £uorescent probe,
the previous destruction of the reduced NADPH, with HCl. NADPH
was quantitated in a di¡erent aliquot of the enzyme treated fraction to
which 0.045 N NaOH was added in order to destroy oxidized NAD.
After heating, 0.03% H2O2-6 N NaOH was added and heated again.
Standard curves with NAD and NADH concentrations of 0.05^0.6
WM were used. The standards were prepared at the same time as the
homogenates and treated in the same way.
3. Results and discussion
3.1. CO2 production from labelled glucose
Radioactive CO2 evolution from labelled glucose was fol-
lowed in oocytes which were microinjected with the hexose
and also in non-perturbed cells to which glucose was added
to the external incubation medium. The results obtained show
that the e⁄ciency of CO2 labelling is the same irrespective of
whether glucose is microinjected into the oocytes or supplied
in the incubation medium. As shown in Fig. 1, most of the
label incorporated in CO2 originates from [1-14C]glucose,
while almost no radioactivity is recovered in CO2 after
[6-14C]glucose administration. The pentose-P cycle provides
the only known mechanism that causes signi¢cant di¡erences
in the CO2 outputs from [1-14C] or [6-14C]glucose. Thus, these
di¡erences have frequently been used as a measure of the
activity of the pathway. However, Larrabee [15] has shown
that the C13C6 di¡erence in CO2 sets only a lower limit to
the £ux from glucose to the pentose phosphate pathway,
which may in fact be considerably higher. The low ratio C6/
C1 obtained in stage VI oocytes suggests that in vivo, CO2
evolution from glucose may be ascribed almost exclusively to
the pentose-P cycle. A similar situation has been reported for
Xenopus laevis oocytes [7].
3.2. E¡ect of microinjected NADP+ on CO2 evolution from
[14C]glucose
Expansion of the oocyte pool of NADP by direct injection
causes a marked stimulation of 14CO2 production from la-
belled glucose. Coinjection of NADP and [1-14C]glucose
(3 nmol each per oocyte) increased the production of 14CO2
about 6^10-fold after 30 min incubation (Fig. 2). The e¡ect
was evident as early as 10 min after injection. This result was
expected since it is generally accepted that the rate of the
pentose-P pathway is not controlled by substrate limitation
but by the availability of the oxidized form of NADP
[11,16,17]. In agreement with these observations, conditions
known to augment the NADP/NADPH ratio result in the
stimulation of the rate of the pentose-P pathway, usually
measured by the production of 14CO2 from [1-14C]glucose
[11,18,19]. The very small production of 14CO2 from
[6-14C]glucose was also stimulated by NADP (data not
shown).
The increase in 14CO2 production depends on the amount
of NADP injected (Fig. 3). Half maximal e¡ects were ob-
tained with 0.4 nmol NADP, which assuming a cell volume
of 3 Wl and uniform distribution of the metabolite inside the
cell, is equivalent to 0.13 mM (disregarding endogenous lev-
els).
The in£uence of glucose concentration on the e¡ects of
injected NADP was studied by coinjection of di¡erent
amounts of [U-14C]glucose and a ¢xed amount (3 nmol per
oocyte) of the nucleotide. In every glucose concentration
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Fig. 1. Time course of CO2 production from di¡erent labelled glu-
coses. Groups of three oocytes in duplicate £asks were incubated
for the indicated times for 14CO2 evolution. A: Oocytes were micro-
injected with 50 nl of saline solution containing 3 nmol (approxi-
mately 30 000 cpm) of [1-14C]glucose (b) or [6-14C]glucose (F). B:
Alternatively, other oocytes were incubated in saline containing 2
mM [1-14C]glucose (b) or [6-14C]glucose (F). The results are ex-
pressed as pmol of CO2 and correspond to the mean of two obser-
vations.
Fig. 2. Time course of CO2 labelling by frog oocytes microinjected
with [1-14C]glucose with or without NADP.Oocytes were microin-
jected with 50 nl of saline solution containing 3 nmol of
[1-14C]glucose (20 000 cpm/nmol) (a). Other oocytes received the
same solution plus 3 nmol of NADP (b). After injection, groups
of three oocytes in duplicate £asks were incubated for the indicated
times for 14CO2 evolution. Results are shown as the mean of two
observations.
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tested, NADP increased 14CO2 formation (Fig. 4). The sys-
tem reached saturation around 10 nmol (3.3 mM) glucose.
The e¡ects of NADP were also observed if glucose was
substituted by other precursors (Table 1). Thus, 14CO2 evolu-
tion from labelled fructose-6-P, glucose-6-P or glucose-1-P
was stimulated roughly to the same extent by NADP (be-
tween four and seven times). Production of 14CO2 from mi-
croinjected glucose-1-P or fructose-6-P may at ¢rst seem sur-
prising. However, we have observed that in oocytes
microinjected with labelled fructose-6-P, the intermediate is
converted within minutes into glucose-6-P (unpublished re-
sults). Similarly, we may expect conversion of injected glu-
cose-1-P into glucose-6-P.
3.3. Speci¢city of NADP+ stimulatory e¡ect
Compounds related to NADP were injected together with
3 nmol of [U-14C]glucose (Table 2). As already mentioned,
NADP stimulates 14CO2 production about 10-fold. In the
presence of NADPH (3 nmol), 14CO2 evolution unexpectedly,
was slightly increased. A probable explanation for this e¡ect
could be an increase in the amount of the oxidized form, as a
response of the glutathione system in order to maintain the
NADP/NADPH ratio. The glutathione system is known to
exist in amphibian tissues (Dr. A. Venturino, personal com-
munication). NAD, NADH or nicotinamide did not stimu-
late 14CO2 production. Phenazine methosulfate, (an arti¢cial
electron acceptor dye), mimicked the e¡ects of NADP even
though only 0.3 nmol per oocyte could be injected (higher
amounts precipitated in the injection micropipette). The abil-
ity of this and related compounds (pyocyanin, methylene blue)
to produce the chemical reoxidation of NADPH, therefore
ensuring a continuous supply of NADP and increasing the
rate of the pathway, has been used in a variety of cells and
organs [11,18^23]. The qualitatively similar e¡ect produced by
phenazine methosulfate and NADP further reinforces the
conclusion that the increase of the pentose-P pathway rate
is due to the expansion of the pool of the oxidized form of
NADP.
3.4. Total pyridine nucleotide levels in oocytes
Intracellular concentrations of oxidized and reduced forms
of pyridine nucleotides were measured in extracts from unper-
turbed oocytes (Table 3). NAD was the most abundant spe-
cies and the values found were signi¢cantly higher than those
of NADP. As in other amphibian species [7], a high
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Table 1
The e¡ect of NADP on CO2 labelling from microinjected [U-14C]
substrates by frog oocytes
Substrate NADP pmol/oocyte/30 min
[U-14C]glucose 3 13 þ 1.1
+ 52 þ 4.9
[U-14C]glucose-6-P 3 8 þ 1.5
+ 41 þ 4.1
[U-14C]glucose-1-P 3 16 þ 1.3
+ 88 þ 9.1
[U-14C]fructose-6-P 3 16 þ 1.2
+ 112 þ 7.6
Oocytes were microinjected with 45 nl of saline containing 3 nmol
(60 000 cpm) of each of the indicated compounds. Other oocytes re-
ceived in addition 3 nmol of NADP. Groups of three oocytes in
duplicate tubes were then incubated in 50 ml of saline during 30
min. 14CO2 evolution was monitored every 10 min. Results are given
as the mean þ S.E.M. of six observations.
Table 2
The e¡ect of NADP or related compounds on the incorporation
of 14C from microinjected [U-14C]glucose into CO2 by frog oocytes
Compounds coinjected
with [U-14C]glucose
CO2 (% of control values)
None 100 þ 5
NADP 982 þ 86
NADPH 180 þ 10
NAD 109 þ 8
NADH 104 þ 7
Phenazine methosulfate 265 þ 11
Nicotinamide 76 þ 10
Oocytes were injected with 45^50 nl of a saline solution containing
3 nmol of [U-14C]glucose alone or in a mixture with 3 nmol of either
of the indicated compounds, except for phenazine methosulfate (only
0.3 nmol). Groups of three oocytes in duplicate tubes were then in-
cubated in 50 ml of saline for 30 min. 14CO2 evolution was monitored
every 10 min. Results are given as the means þ S.E.M. of the percent-
age of radioactivity in the controls.
Fig. 3. E¡ect of the amount of microinjected NADP on CO2 la-
belling from [1-14C]glucose.Oocytes were microinjected with 48 nl of
a saline solution containing 2.9 nmol of [1-14C]glucose (24 000 cpm/
nmol) plus the indicated amounts of NADP. After injection,
groups of three oocytes in duplicate £asks were incubated for
20 min. Results are shown as the mean of two observations.
Fig. 4. In£uence of the amount of microinjected glucose on the ef-
fect of NADP on CO2 labelling. Oocytes were microinjected with
45 nl of saline solutions containing variable amounts (0.9^16.3
nmol) of [U-14C]glucose (a). Speci¢c radioactivity of glucose varied
from 4300 to 32 000 cpm/nmol. Other oocytes were injected with the
same solutions containing 2.7 nmol of NADP (b). Afterwards,
groups of three oocytes in duplicate £asks were incubated for 30
min for 14CO2 evolution.
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NADPH/NADP ratio of 4.3 and a ratio of 1.7 for NAD/
NADH are maintained by Caudiverbera oocytes at this stage
of development. As mentioned above, the calculated NADP
concentration necessary for 50% stimulation of CO2 produc-
tion is 130 WM, a value which is around seven times higher
than the total intracellular concentration of the nucleotide in
the oocyte (19 WM).
It has been reported that NADPH strongly inhibits glucose-
6-P dehydrogenase [24^28] and 6-P-gluconate dehydrogenase
[24,25,29,30]. The inhibition is competitive with respect to
NADP and therefore depends on the NADP/NADPH ra-
tio. These considerations clearly indicate that the activities of
the pentose-P pathway dehydrogenases are severely inhibited
by the redox conditions generally prevailing in most cells, frog
oocytes among them. The activity of glucose-6-P dehydrogen-
ase in oocyte homogenates is 2.1 þ 0.3 U/g wet weight which
corresponds to a potential maximal velocity of about 12 600
pmol/min per oocyte [2]. Injected labelled glucose or glucose-
6-P at saturating amounts (around 10 nmol/oocyte) produced
at most 2^5 pmol/min of labelled CO2 (not shown). The un-
perturbed oocyte contains approximately 56 pmol of NADP
(Table 3). Even though this amount was increased around 50-
fold by microinjection, the production of 14CO2 was still far
below the maximal capacity of glucose-6-P dehydrogenase.
We do not know if the oocyte dehydrogenases are inhibited
by NADPH, and if all the injected pyridine nucleotide is
available for the enzymes. However, the rough calculation
suggests that additional factors play a role in maintaining a
subdued activity of the pathway.
The stage VI grown oocyte seems to be in a metabolic
situation in which, due to the low levels of NADP (19
WM) and probable inhibition of the dehydrogenases by
NADPH, the pentose phosphate pathway is operating at
very low levels in vivo. The pentose phosphate pathway has
been shown to operate in vivo in cellular trophoblasts in cul-
ture [23]. Our experimental model allows us the study of the
pathway in vivo and in a single cell. The controlled variation
of the intracellular levels of glucose and NADP together
with the quantitation of the intracellular levels of NADP
and NADPH, leads us to the conclusion that in the oocytes,
NADP availability limits the operation of the pentose phos-
phate cycle in vivo. The transformation of the oocyte into the
mature egg triggers a number of structural and biochemical
occurrences. Fluctuations in cAMP levels, changes in pH,
protein phosphorylation and dephosphorylation, and ion
£ux changes have been described [31]. Increased metabolic
demands are supposed to be covered by accumulated stores
of glycogen and lipids. These changes in energy metabolism
have been related to changes in the redox potential of pyridine
nucleotides. Thus, variations in the level of such metabolites
may play an important role in the regulation of the early
events of maturation ¢nally leading to fertilization and cell
division.
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Table 3
Oxidized and reduced pyridine nucleotide levels in frog oocytes
Pyridine nucleotide pmol/oocyte Intracelullar concentration (WM)
NAD 327 þ 1.5 125.7
NADH 220 þ 10.3 73.5
NADP 56 þ 12.5 18.8
NADPH 243 þ 9.1 81.2
Groups of 10 non-perturbed oocytes were homogenized and further
treated as described in Section 2. Concentrations values were calcu-
lated assuming that pyridine nucleotides are uniformly distributed in
an intracellular volume of 3 Wl. Results are given as the means
þ S.E.M. of four observations.
A. Preller et al./FEBS Letters 446 (1999) 149^152152
